Metabolic

  • Hypertriglyceridemia
  • Hyperuricemia, Hypertension
  • Hyperuricemia, Renal Impairment, Gout
  • Secondary Hyperparathyroidism
  • Diabetes
  • Diabetic Foot Ulcers
  • Diabetic Nephropathy
  • Obesity
  • Metabolic Syndrome, Hypertension
  • Metabolic Syndrome
  • Type I Diabetes
  • Type II Diabetes

Integrium’s Metabolic Clinical Trial Experience

Metabolic

Next

Overall Metabolic Experience
Study Phase Indication # Patients # Sites
II Hypertriglyceridemia 60 2
II Hyperuricemia, Hypertension 120 40
II Hyperuricemia, Renal Impairment, Gout 240 50
II Hyperuricemia, Hypertension 240 50
IIa Secondary Hyperparathyroidism 12 1
IIb Secondary Hyperparathyroidism 60 15
III Diabetic Foot Ulcers 428 30
III Diabetic Foot Ulcers 428 30
III Diabetic Foot Ulcers 200 50
IIIb Obesity 66 7
IV Metabolic Syndrome, Hypertension 84 1
IV Metabolic Syndrome 220 30

Next